These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17691027)

  • 1. Experimental Leishmania (L.) amazonensis leishmaniasis: characterization and immunogenicity of subcellular fractions.
    do Valle TZ; Gaspar EB; Souza-Lemos C; Souza CS; Márquez FB; Baetas-da-Cruz W; d'Escofier LN; Côrte-Real S; Calabrese KS; da Costa SC
    Immunol Invest; 2007; 36(4):473-92. PubMed ID: 17691027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
    González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
    Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.
    Jaafari MR; Badiee A; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F
    Vaccine; 2007 Aug; 25(32):6107-17. PubMed ID: 17629372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the vaccination of C57BL/6 mice against infection with different species of Leishmania].
    Monjour L; Ogunkolade W; Pointet P; Vouldoukis I
    C R Acad Sci III; 1985; 301(18):803-6. PubMed ID: 3936605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, purification, characterization and antigenic evaluation of GPI-anchored membrane proteins from Leishmania (Viannia) braziliensis.
    Rojas A; García-Lugo P; Crisante G; Añez-Rojas N; Añez N
    Acta Trop; 2008 Feb; 105(2):139-44. PubMed ID: 18054342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model.
    Ribeiro JG; Ferreira AS; Macedo SRA; Rossi NRDLP; da Silva MCP; Guerra RNM; de Barros NB; Nicolete R
    Int Immunopharmacol; 2017 Jun; 47():227-230. PubMed ID: 28433944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
    Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
    Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful vaccination against Leishmania chagasi infection in BALB/c mice with freeze-thawed Leishmania antigen and Corynebacterium parvum.
    Vilela Mde C; Gomes DC; Marques-da-Silva Ede A; Serafim TD; Afonso LC; Rezende SA
    Acta Trop; 2007; 104(2-3):133-9. PubMed ID: 17919443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH; Gentil LG; Dias SS; Fedeli CE; Katz S; Barbiéri CL
    Vaccine; 2008 Jan; 26(5):677-85. PubMed ID: 18160187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal extension of Leishmania pifanoi amastigote-specific cysteine proteinase Lpcys2: a putative function in macrophage infection.
    Marín-Villa M; Vargas-Inchaustegui DA; Chaves SP; Tempone AJ; Dutra JM; Soares MJ; Ueda-Nakamura T; Mendonça SC; Rossi-Bergmann B; Soong L; Traub-Csekö YM
    Mol Biochem Parasitol; 2008 Nov; 162(1):52-9. PubMed ID: 18694784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice.
    Afonso-Cardoso SR; Rodrigues FH; Gomes MA; Silva AG; Rocha A; Guimaraes AH; Candeloro I; Favoreto S; Ferreira MS; de Souza MA
    Korean J Parasitol; 2007 Dec; 45(4):255-66. PubMed ID: 18165707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies against defined Leishmania antigens protect mice against infection by different species of Leishmania].
    Monjour L; Berneman A; Vouldoukis I; Domurado M; Guillemin MC; Chopin C; Alfred C; Roseto A
    C R Acad Sci III; 1985; 300(9):395-8. PubMed ID: 3922585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation vaccines against leishmaniasis.
    Coler RN; Reed SG
    Trends Parasitol; 2005 May; 21(5):244-9. PubMed ID: 15837614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
    Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes.
    Felizardo TC; Toma LS; Borges NB; Lima GM; Abrahamsohn IA
    Parasitology; 2007 Nov; 134(Pt 12):1699-707. PubMed ID: 17655808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility to and the characteristics of the course of experimental leishmaniasis in different species of mammals infected with Leishmania major, L. turanica and L. gerbilli].
    Strelkova MV
    Med Parazitol (Mosk); 1991; (1):35-9. PubMed ID: 2067472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta).
    Porrozzi R; Teva A; Amaral VF; Santos da Costa MV; Grimaldi G
    Am J Trop Med Hyg; 2004 Sep; 71(3):297-305. PubMed ID: 15381810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major infections in Phlebotomus duboscqi fed on murine models immunized with L. major subcellular antigens and sandfly gut antigens.
    Mbati PA; Anjili CO; Odongo S; Ogaja P; Tonui W
    Onderstepoort J Vet Res; 2000 Mar; 67(1):57-63. PubMed ID: 10843323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American tegumentary leishmaniasis: a quantitative analysis of Langerhans cells presents important differences between L. (L.) amazonensis and Viannia subgenus.
    Xavier MB; Silveira FT; Demachki S; Ferreira MM; do Nascimento JL
    Acta Trop; 2005 Jul; 95(1):67-73. PubMed ID: 15935321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.